Cargando…
Measles Vaccination in Presence of Measles Antibody May Enhance Child Survival
Background: In trials of early two-dose measles vaccination (MV), with the first dose being given before 9 months of age, vaccination in the presence of maternal antibody reduced mortality 2- to 3-fold compared with MV in the presence of no measles antibody. We tested this finding in two historical...
Autores principales: | Benn, Christine S., Martins, Cesário L., Andersen, Andreas, Fisker, Ane B., Whittle, Hilton C., Aaby, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020693/ https://www.ncbi.nlm.nih.gov/pubmed/32117827 http://dx.doi.org/10.3389/fped.2020.00020 |
Ejemplares similares
-
Measles Vaccination in the Presence or Absence of Maternal Measles Antibody: Impact on Child Survival
por: Aaby, Peter, et al.
Publicado: (2014) -
Does oral polio vaccine have non-specific effects on all-cause mortality? Natural experiments within a randomised controlled trial of early measles vaccine
por: Aaby, Peter, et al.
Publicado: (2016) -
Interaction between neonatal vitamin A supplementation and timing of measles vaccination: A retrospective analysis of three randomized trials from Guinea-Bissau()
por: Benn, Christine S., et al.
Publicado: (2014) -
Is early measles vaccination associated with stronger survival benefits than later measles vaccination?
por: Hansen, Jesper Sloth, et al.
Publicado: (2018) -
The optimal age of measles immunisation in low-income countries: a secondary analysis of the assumptions underlying the current policy
por: Aaby, Peter, et al.
Publicado: (2012)